News
Hims & Hers Rallies After Novo Nordisk Deal on Wegovy
Shares of online pharmacy Hims & Hers surged after it struck a deal with Danish obesity drug maker Novo Nordisk to sell its Wegovy drug in the U.S. In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions,
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
Health and Me on MSN4h
Novo Nordisk Wins Legal Battle That Bars Many Compounded Versions Of Wegovy, OzempicHundreds of thousands of people flocked to these compounding firms when they didn't have enough money to afford the costly ...
Stocktwits on MSN3d
Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s BullishNovo Nordisk (NVO) announced on Friday that it has secured a legal victory against compounders selling unauthorized versions ...
The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...
The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...
Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...
Novo Nordisk (NVO) won a key case Thursday to ... which are supposed to halt selling compounded semaglutide — the active ingredient in diabetes drug Ozempic and weight-loss drug Wegovy ...
Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the drugmaker's blockbuster weight loss drug Wegovy ...
A federal judge April 24 rejected a bid by compounding pharmacies to continue selling less expensive copies of semaglutide, Novo Nordisk's blockbuster drug sold under the brands Wegovy and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback